Table 3 rSO2 values at baseline and parenchymal transection (phase 5)
|  | TN(n = 36) | TMH (n = 36) | p-value |
|---|---|---|---|
Left | Â | ||
 Baseline | 71.4 ± 6.0 | 73.0 ± 5.2 | 0.235 |
 Mean rSO2 of phase 5 | 65.9 ± 4.5 | 71.5 ± 5.4 | 0.000 |
 Min rSO2 of phase 5 | 62.3 ± 5.3 | 67.3 ± 7.4 | 0.002 |
 Percentage change in Mean rSO2 of phase 5 from baseline (%ΔrSO2 ) | -7.5 ± 4.8 | -1.8 ± 7.0 | 0.000 |
 Percentage change in Min rSO2 of phase 5 from baseline (%ΔrSO2 ) | -12.6 ± 6.6 | -7.7 ± 9.7 | 0.015 |
Right | Â | ||
 Baseline | 73.2 ± 4.8 | 72.6 ± 4.6 | 0.617 |
 Mean rSO2 of phase 5 | 67.9 ± 3.2 | 71.5 ± 4.1 | 0.000 |
 Min rSO2 of phase 5 | 64.0 ± 4.1 | 67.4 ± 5.3 | 0.003 |
 Percentage change in Mean rSO2 of phase 5 from baseline (%ΔrSO2 ) | -7.1 ± 4.6 | -1.4 ± 5.4 | 0.000 |
 Percentage change in Min rSO2 of phase 5 from baseline (%ΔrSO2 ) | -12.4 ± 6.0 | -7.0 ± 7.2 | 0.001 |